I

(redirected from Wilms' tumor)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to Wilms' tumor: Wilms tumour

I

Fifth letter of a Nasdaq stock symbol specifying that it is the third preferred bond of the company.

I

1. On a stock transaction table, a symbol indicating that a dividend was paid after a stock split.

2. A symbol appearing next to a bond listed on NASDAQ indicating that the bond is a company's third preferred bond. All NASDAQ listings use a four-letter abbreviation; if the letter "I" follows the abbreviation, this indicates that the security being traded is a third preferred bond.

i

Used in the dividend column of stock transaction tables to indicate that the dividend was paid after a stock dividend or split: Lehigh s.20i.
Mentioned in ?
References in periodicals archive ?
A report from the National Wilms' Tumor Study Pathology Center.
The Whitehead group would also like to use the mouse as a model for studying how these faulty suppressor genes lead to Wilms' tumor.
A review of the Wilms' Tumor (Nephroblastoma) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
Occupational exposures among fathers of children with Wilms' tumor.
Tess Beach, 12, a 7th grader at Cal Young Middle School in Eugene, who was treated at Doernbecher for a Wilms' tumor.
Expression of the Wilms' tumor gene WT1 in human malignant mesothelioma cell lines and relationship to platelet-derived growth factor A and insulin-like growth factor 2 expression.
Vincristine is indicated for acute leukemia and also has been shown to be useful in combination with other oncolytic agents in Hodgkin's disease, non-Hodgkin's malignant lymphomas, rhabdomyosarcoma, neuroblastoma, and Wilms' tumor.
Experts from both Stanford University and UCLA Medical Centers have stated, during their testimony, that the technique for removing a kidney with a Wilms' tumor or another form of cancerous tumor is essentially the same, be it an adult or a nine year old child.
In 1993, 9-year-old Carley Christie was diagnosed and treated for Wilms' tumor, a rare and life-threatening form of kidney cancer.
He initially identified the first function of the Wilms' tumor gene product WT1, which causes pediatric kidney tumors.